ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,547,000 | -5.8% | 285,100 | +3.7% | 0.01% | 0.0% |
Q3 2016 | $3,765,000 | +80.1% | 275,000 | -2.8% | 0.01% | +100.0% |
Q2 2016 | $2,090,000 | +15.2% | 282,800 | -3.9% | 0.00% | 0.0% |
Q1 2016 | $1,814,000 | +23.5% | 294,200 | +25.2% | 0.00% | -25.0% |
Q4 2015 | $1,469,000 | +7.1% | 235,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,372,000 | -18.6% | 235,000 | +15.3% | 0.00% | 0.0% |
Q2 2015 | $1,686,000 | +2.2% | 203,900 | +1.8% | 0.00% | 0.0% |
Q1 2015 | $1,650,000 | +22.5% | 200,300 | +2.2% | 0.00% | -20.0% |
Q4 2014 | $1,347,000 | +27.3% | 196,000 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $1,058,000 | -15.3% | 196,000 | 0.0% | 0.00% | -20.0% |
Q2 2014 | $1,249,000 | -24.3% | 196,000 | -4.3% | 0.01% | -16.7% |
Q1 2014 | $1,651,000 | +53.9% | 204,900 | +30.2% | 0.01% | +50.0% |
Q4 2013 | $1,073,000 | -62.9% | 157,400 | 0.0% | 0.00% | -66.7% |
Q3 2013 | $2,896,000 | 0.0% | 157,400 | -5.0% | 0.01% | -7.7% |
Q2 2013 | $2,896,000 | – | 165,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |